http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180004814-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
filingDate 2016-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58b3671b5187a573ee407bc6ab09bb95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ef46d726683280d14e9506665ab0e89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0aa3a9a1aa37e45976cb555b76ca592
publicationDate 2018-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20180004814-A
titleOfInvention Selective progesterone receptor modulator (SPRM) therapy
abstract The present invention relates to the use of a progesterone receptor antagonist, namely (11?, 17?) -17-hydroxy-11- [4- (methylsulfonyl) phenyl] -17- (pentafluoro- (Myoma, uterine leiomyoma) comprising estra-4,9-dien-3-one. In addition, the present invention provides methods of treating uterine fibroids (myoma, uterine leiomyoma) and / or reducing symptoms associated with uterine fibroids (myoma, uterine leiomyoma) and uterine fibroids, as well as methods of treating hypermenorrhea (HMB) .
priorityDate 2015-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422140181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452340035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415778248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3015207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429647324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6527064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419877127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412224215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154002104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448226434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416218147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451483236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7311726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12291
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23712892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18604267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420605453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3021735

Total number of triples: 49.